Industry groups petition the FDA over off-label rule
Mar 20, 2017 - Medical Marketing & Media (MMM)
UPDATE: The FDA announced March 17 that it would delay the rule until March 19, 2018.
Industry groups are taking aim at a rule created by the Food and Drug Administration that could restrict drugmakers' truthful and non-misleading promotion of its drugs - commonly referred to as off-label promotion - by expanding the evidence the agency can use to assert that a drug has been misbranded.
The FDA filed the final rule in the Federal Register on January 9. A citizen petition was filed by...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
